Tag: pediatric exclusivity
2
FebruaryPediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents but blocks generic approvals, creating a powerful regulatory tool that improves children's drug safety.
Recent posts
-
3 Nov 2025
Probiotics and Immunosuppressants: Understanding Infection Risks and Safe Use
-
29 Nov 2025
Antacids and Antibiotics: How to Time Your Doses to Avoid Treatment Failure
-
28 Dec 2025
Documentation Requirements for Recording Generic Substitution Decisions in Pharmacy Practice
-
4 Jan 2026
How to Use Secure Messaging to Ask Medication Questions
-
12 Oct 2025
Effective Speech Therapy Techniques for Stroke Survivors